Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on May 28, 2025
HCVC leads kyron.bio €5.5M round to use glycan engineering for advanced drug design
GlobeNewswire
·
May 28, 2025
Paris, May 28, 2025 (GLOBE NEWSWIRE) -- One of the biggest challenges facing biologic drug developers are varying efficacy and the dangers of side effects. Biotechnology company kyron.bio today announced a €5.5 million funding round to solve these issues …
Alpha Tau to Present at Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
JERUSALEM, May 28, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will present at the …
Vittoria Biotherapeutics to Share Trials-in-Progress Presentation from Phase 1 Study of VIPER-101 at ASCO 2025 Annual Meeting
GlobeNewswire
·
May 28, 2025
PHILADELPHIA, May 28, 2025 (GLOBE NEWSWIRE) -- Vittoria Biotherapeutics Inc., a clinical-stage immunotherapy company specializing in the development of innovative therapies for hard-to-treat diseases, today announced it will present a trials-in-progress …
iTeos Therapeutics Announces Its Intention to Wind Down Operations
GlobeNewswire
·
May 28, 2025
- Board of Directors intends to cease operations - Company to focus efforts on selecting best path to deliver near-term value to shareholders - Exploring potential asset sales including EOS-984, EOS-215, and a preclinical obesity program targeting ENT1 …
SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study
GlobeNewswire
·
May 28, 2025
First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical hold Resumption of dosing in this study triggers a $10M milestone payment from GSK plus an additional $20M milestone due in six months; as previously disclosed GSK …
Ernexa Therapeutics Announces New Data to be Presented at ASCO Annual Meeting 2025
GlobeNewswire
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that new data will be presented at the American Society …
Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
SEATTLE and VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …
Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
GlobeNewswire
·
May 28, 2025
WEXFORD, Pa. and PRINCETON, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- SNAP Biosciences, Inc a majority-owned subsidiary of Coeptis Therapeutics Holdings Inc. (Nasdaq: COEP) and Monarch Therapeutics Inc., a biotechnology company pioneering next-generation …
SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy
GlobeNewswire
·
May 28, 2025
Coverage marks SeaStar Medical’s second award by CMS for reimbursement of medical expenses for Medicare and Medicaid patients in a clinical trial Stands out as rare award with less than 100 clinical trials covered annually DENVER, May 28, 2025 (GLOBE …
Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 for the Treatment of Prostate Cancer
GlobeNewswire
·
May 28, 2025
NEEDHAM, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …
4DMT to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 28, 2025
EMERYVILLE, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment …
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results
GlobeNewswire
·
May 28, 2025
LAKEWOOD, Colo., May 28, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“ …
genXtraits Inc. expands collaboration with The New Zealand Institute for Plant & Food Research Limited to increase vitamin C in crops, including corn and soybean
GlobeNewswire
·
May 28, 2025
ALAMEDA, Calif. , May 28, 2025 (GLOBE NEWSWIRE) -- genXtraits Inc. (genXtraits) today announced that it has expanded its license and collaboration agreement with The New Zealand Institute for Plant and Food Research Limited (Plant …
Design Therapeutics to Participate in 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
CARLSBAD, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will present during the …
BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001
GlobeNewswire
·
May 28, 2025
VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic …
Elutia Strengthens Drug-Eluting Biomatrix Platform with Peer-Reviewed Publication of Novel EluPro™ Testing Method
GlobeNewswire
·
May 28, 2025
SILVER SPRING, Md., May 28, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced the publication of a peer-reviewed article describing the first validated method …
Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference 2025
GlobeNewswire
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that Akebia Executive Management will …
A Future Where Women’s Health Leads: The MUHC Foundation Launches $5 Million Movement for Change
GlobeNewswire
·
May 28, 2025
MONTREAL, May 28, 2025 (GLOBE NEWSWIRE) -- Women deserve health care designed with them in mind. They deserve research that includes them, care that reflects their needs, and a future where their well-being is a top priority. Today, on this International …
Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
BOSTON, May 28, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced that the Company will participate in a …
Un avenir où la santé des femmes est une priorité : La Fondation du CUSM lance un mouvement de 5 M$ pour changer l’avenir des soins
GlobeNewswire
·
May 28, 2025
MONTRÉAL, 28 mai 2025 (GLOBE NEWSWIRE) -- Les femmes méritent des soins de santé pensés pour elles. Elles méritent de faire partie intégrante de la recherche, de recevoir des soins adaptés à leurs besoins et d’avoir accès à un avenir où leur bien-être est …